PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 184 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $57,670 | -3.0% | 1,418 | +15.5% | 0.01% | -11.1% |
| Q1 2023 | $59,484 | +44.3% | 1,228 | +13.7% | 0.01% | +50.0% |
| Q4 2022 | $41,224 | -23.7% | 1,080 | 0.0% | 0.01% | -33.3% |
| Q3 2022 | $54,000 | +25.6% | 1,080 | 0.0% | 0.01% | +28.6% |
| Q2 2022 | $43,000 | +7.5% | 1,080 | 0.0% | 0.01% | +40.0% |
| Q1 2022 | $40,000 | -7.0% | 1,080 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $43,000 | +7.5% | 1,080 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $40,000 | -13.0% | 1,080 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $46,000 | -9.8% | 1,080 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $51,000 | -10.5% | 1,080 | +16.1% | 0.01% | -11.1% |
| Q4 2020 | $57,000 | +119.2% | 930 | +66.4% | 0.01% | +80.0% |
| Q3 2020 | $26,000 | +100.0% | 559 | +124.5% | 0.01% | +66.7% |
| Q2 2020 | $13,000 | +18.2% | 249 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $11,000 | – | 249 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 160,372 | $7,594,000 | 6.15% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 408,000 | $19,319,000 | 5.11% |
| RTW INVESTMENTS, LP | 5,293,966 | $250,669,000 | 3.91% |
| GEORGE KAISER FAMILY FOUNDATION | 72,105 | $9,925,000 | 2.07% |
| SECTORAL ASSET MANAGEMENT INC | 504,928 | $23,908,000 | 1.81% |
| Redwood Investments, LLC | 385,014 | $18,230,000 | 1.60% |
| ARMISTICE CAPITAL, LLC | 1,396,000 | $66,101,000 | 1.52% |
| Integral Health Asset Management, LLC | 100,100 | $4,740,000 | 1.35% |
| Sofinnova Investments, Inc. | 466,840 | $22,105,000 | 1.33% |
| Chubb Ltd | 8,180 | $387,000 | 1.10% |